A large-scale population-based study reveals that gp42-IgG antibody is protective against Epstein-Barr virus-associated nasopharyngeal carcinoma.
Kong XW, Bu GL, Chen H, Huang YH, Liu Z, Kang YF, Li YC, Yu X, Wu BH, Li ZQ, Chen XC, Xie SH, Lin DF, Li T, Yan SM, Han RK, Huang N, Wang QY, Li Y, Zhang A, Zhong Q, Huang XM, Ye W, Ji MF, Cai YL, Cao SM, Zeng MS.
Kong XW, et al. Among authors: li zq.
J Clin Invest. 2024 Nov 26:e180216. doi: 10.1172/JCI180216. Online ahead of print.
J Clin Invest. 2024.
PMID: 39589824
Free article.